These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9534037)

  • 1. Treatment of hyperthyroidism with radioactive iodine.
    Kaplan MM; Meier DA; Dworkin HJ
    Endocrinol Metab Clin North Am; 1998 Mar; 27(1):205-23. PubMed ID: 9534037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
    Bogazzi F; Giovannetti C; Fessehatsion R; Tanda ML; Campomori A; Compri E; Rossi G; Ceccarelli C; Vitti P; Pinchera A; Bartalena L; Martino E
    J Clin Endocrinol Metab; 2010 Jan; 95(1):201-8. PubMed ID: 19906789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
    Andrade VA; Gross JL; Maia AL
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodine treatment of hyperthyroidism. Success rate and influence of thyrostatic medication.
    Ghadban WK; Zirie MA; Al-Khateeb DA; Jayyousi AA; Mobayedh HM; El-Aloosy AS
    Saudi Med J; 2003 Apr; 24(4):347-51. PubMed ID: 12754531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of treatment of hyperthyroidism.
    Bringmann IM; van Leeuwen BL; Hennemann G; Beckett GJ; Toft AD
    J Endocrinol Invest; 1999 Apr; 22(4):250-6. PubMed ID: 10342357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-ablative hypothyroidism.
    Yaqub A; Choudhry MI; Wheaton J; Gress T
    W V Med J; 2011; 107(2):37-40. PubMed ID: 21476476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of radioactive iodine in the management of hyperthyroidism in children.
    Rivkees SA
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Nov; 1(3):255-64. PubMed ID: 12477291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK; Larsen PR
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
    Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of post-radioactive iodine relapse of hyperthyroidism: comparison of long-term methimazole and radioactive iodine treatment.
    Saadat N; Azizi F; Abdi H; Amouzegar A
    J Endocrinol Invest; 2022 Oct; 45(10):1919-1924. PubMed ID: 35610532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up results in children and adolescents treated with radioactive iodine (131I) for hyperthyroidism.
    Safa AM; Schumacher OP; Rodriguez-Antunez A
    N Engl J Med; 1975 Jan; 292(4):167-71. PubMed ID: 45842
    [No Abstract]   [Full Text] [Related]  

  • 13. Case selection and restrictions recommended to patients with hyperthyroidism in South America.
    Romaldini JH
    Thyroid; 1997 Apr; 7(2):225-8. PubMed ID: 9133690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperthyroidism--advantages and disadvantages of pharmacologic, surgical, and radioactive iodine treatments].
    Meier CA
    Ther Umsch; 1999 Jul; 56(7):364-8. PubMed ID: 10434772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
    Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hyper- and hypothyroidism.
    McDougall IR
    J Clin Pharmacol; 1981; 21(8-9):365-84. PubMed ID: 6168663
    [No Abstract]   [Full Text] [Related]  

  • 17. [Radioactive iodine therapy in Graves' hyperthyroidism].
    Andrade VA; Gross JL; Maia AL
    Arq Bras Endocrinol Metabol; 2004 Feb; 48(1):159-65. PubMed ID: 15611828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of propylthiouracil on the efficacy of radioiodine (I-131) therapy in graves hyperthyroidism].
    de Souza MV; Buescu A; Vaisman M; de Souza HF; Luiz RR
    Arq Bras Endocrinol Metabol; 2006 Dec; 50(6):1088-95. PubMed ID: 17221116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
    Walter MA; Christ-Crain M; Eckard B; Schindler C; Nitzsche EU; Müller-Brand J; Müller B
    Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graves' Disease Pharmacotherapy in Women of Reproductive Age.
    Prunty JJ; Heise CD; Chaffin DG
    Pharmacotherapy; 2016 Jan; 36(1):64-83. PubMed ID: 26799350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.